National Research Center for Sexual Medicine and Department of Urology, Inha University School of Medicine, Incheon, Korea.
J Sex Med. 2014 Feb;11(2):411-23. doi: 10.1111/jsm.12380. Epub 2013 Nov 20.
Recently, much attention has focused on stem cell therapy; bone marrow-derived stem cells (BMSCs) are one of the most studied mesenchymal stem cells used in the field of erectile dysfunction (ED). However, a major limitation for the clinical application of stem cell therapy is the heterogeneous nature of the isolated cells, which may cause different treatment outcomes.
We investigated the effectiveness of mouse clonal BMSCs obtained from a single colony by using subfractionation culturing method (SCM) for erectile function in a mouse model of cavernous nerve injury (CNI).
Twelve-week-old C57BL/6J mice were divided into four groups: sham operation group, bilateral CNI group receiving a single intracavernous (IC) injection of phosphate-buffered saline (20 μL) or clonal BMSCs (3 × 10(5) cells/20 μL), and receiving a single intraperitoneal (IP) injection of clonal BMSCs (3 × 10(5) cells/20 μL).
The clonal BMSC line was analyzed for cell-surface epitopes by using fluorescence-activated cell sorting and for differentiation potential. Two weeks after CNI and treatment, erectile function was measured by electrically stimulating the cavernous nerve. The penis was harvested for histologic examinations and Western blot analysis.
Clonal BMSCs expressed cell surface markers for mesenchymal stem cells and were capable of differentiating into several lineages, including adipogenic, osteogenic, and chondrogenic cells. Both IC and IP injections of clonal BMSCs significantly restored cavernous endothelial and smooth muscle content, and penile nNOS and neurofilament content in CNI mice. IC injection of clonal BMSCs induced significant recovery of erectile function, which reached 90-100% of the sham control values, whereas IP injection of clonal BMSCs partially restored erectile function.
We established a homogeneous population of mouse clonal BMSCs using SCM; clonal BMSCs successfully restored erectile function in CNI mice. The homogeneous nature of clonal mesenchymal stem cells may allow their clinical applications.
最近,人们对干细胞治疗的关注度很高;骨髓源性干细胞(BMSCs)是研究最多的间充质干细胞之一,用于治疗勃起功能障碍(ED)领域。然而,干细胞治疗的临床应用的一个主要局限性是分离细胞的异质性,这可能导致不同的治疗结果。
我们通过亚分离培养法(SCM)从小鼠单个菌落中获得的克隆 BMSCs 来研究其对海绵体神经损伤(CNI)模型中小鼠的勃起功能的影响。
将 12 周龄 C57BL/6J 小鼠分为 4 组:假手术组、双侧 CNI 组(接受单次海绵体内(IC)注射磷酸盐缓冲盐水(20μL)或克隆 BMSCs(3×10(5)个细胞/20μL),以及单次腹腔内(IP)注射克隆 BMSCs(3×10(5)个细胞/20μL)。
使用流式细胞术分析克隆 BMSC 系的细胞表面表型,并分析其分化潜能。CNI 及治疗后 2 周,通过电刺激海绵体神经测量勃起功能。取阴茎进行组织学检查和 Western blot 分析。
克隆 BMSCs 表达间充质干细胞的细胞表面标志物,并能分化为多种谱系,包括脂肪细胞、成骨细胞和软骨细胞。IC 和 IP 注射克隆 BMSCs 均可显著恢复 CNI 小鼠海绵体内皮和平滑肌含量以及阴茎 nNOS 和神经丝含量。IC 注射克隆 BMSCs 可显著恢复勃起功能,恢复程度达到 sham 对照组的 90-100%,而 IP 注射克隆 BMSCs 则部分恢复了勃起功能。
我们使用 SCM 建立了一个均质的小鼠克隆 BMSC 群体;克隆 BMSCs 成功恢复了 CNI 小鼠的勃起功能。克隆间充质干细胞的均质性可能使其临床应用成为可能。